Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 1/2020

Content (33 Articles)

Open Access Phlebothrombosis

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism

Alexander Solms, Stefan Willmann, Isabel Reinecke, Theodore E. Spiro, Gary Peters, Jeffrey I. Weitz, Wolfgang Mueck, Dirk Garmann, Stephan Schmidt, Liping Zhang, Keith A. A. Fox, Scott D. Berkowitz

Open Access Rivaroxaban

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism

Isabel Reinecke, Alexander Solms, Stefan Willmann, Theodore E. Spiro, Gary Peters, Jeffrey I. Weitz, Wolfgang Mueck, Dirk Garmann, Stephan Schmidt, Liping Zhang, Keith A. A. Fox, Scott D. Berkowitz

Open Access Stroke

Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation

Liping Zhang, Xiaoyu Yan, Keith A. A. Fox, Stefan Willmann, Partha Nandy, Scott D. Berkowitz, Anne Hermanowski-Vosatka, Jeffrey I. Weitz, Alexander Solms, Stephan Schmidt, Manesh Patel, Gary Peters

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

Geoffrey D. Barnes, Allison Burnett, Arthur Allen, Marilyn Blumenstein, Nathan P. Clark, Adam Cuker, William E. Dager, Steven B. Deitelzweig, Stacy Ellsworth, David Garcia, Scott Kaatz, Tracy Minichiello

Comparison of warfarin versus DOACs in patients with concomitant indication for oral anticoagulation undergoing TAVI; results from the ATLAS registry

Konstantinos Kalogeras, Richard J. Jabbour, Neil Ruparelia, Samuel Watson, Tito Kabir, Toru Naganuma, Manolis Vavuranakis, Sunao Nakamura, Iqbal S. Malik, Ghada Mikhail, Miles Dalby, Vasileios Panoulas

Characterization of circulating thrombin in patients with septic shock: a prospective observational study

Tobias Becher, Jens Müller, Ibrahim Akin, Stefan Baumann, Ksenija Stach, Martin Borggrefe, Bernd Pötzsch, Dirk Loßnitzer

Circulating heparan sulfate chains and body weight contribute to anti-Xa levels in cancer patients using the prophylactic dose of enoxaparin

Corinne Maurice-Dror, Michael Litvak, Anat Keren-Politansky, Shanny Ackerman, Nissim Haim, Yona Nadir

Open Access Ticagrelor

Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition

Joao D. Dias, Torben Pottgiesser, Jan Hartmann, Daniel Duerschmied, Christoph Bode, Hardean E. Achneck

Factors associated with pregnancy outcomes in women with a history of cerebral sinus venous thrombosis

Amihai Rottenstreich, Harel Gershgoren, Galia Spectre, Nael Da’as, Ohad S. Bentur, Gabriel Levin, Yosef Kalish

Right ventricular strain in patients with pulmonary embolism and syncope

Donya Mohebali, Benedikt H. Heidinger, Stephanie A. Feldman, Jason D. Matos, Dominique Dabreo, Ian McCormick, Diana Litmanovich, Warren J. Manning, Brett J. Carroll

Performance of the right ventricular outflow tract/aortic diameter as a novel predictor of risk in patients with acute pulmonary embolism

Alexandru Marginean, Andrew Putnam, Taishi Hirai, Anthony Serritella, Stephanie A. Besser, Margaret Lee, Janet Friant, John Blair, Atman Shah, Sandeep Nathan, Jonathan Chung, Jonathan Paul

Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis

Koji Tanaka, Shoji Matsumoto, Konosuke Furuta, Takeshi Yamada, Sukehisa Nagano, Kei-ichiro Takase, Taketo Hatano, Ryo Yamasaki, Jun-ichi Kira

Left atrial size measured on CT pulmonary angiography: another parameter of pulmonary embolism severity? A systematic review

Marco Zuin, Gianluca Rigatelli, Stefano Turchetta, Pietro Zonzin, Giovanni Zuliani, Loris Roncon

Pharmacist involvement in clinical assessment and laboratory testing for heparin-induced thrombocytopenia

Amanda J. Condon, Adam J. Hood, Katie L. Willenborg, Kraig Kumfer, Anne E. Rose

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors

Mathieu Artifoni, Gwenvael Danic, Giovanni Gautier, Pascal Gicquel, David Boutoille, François Raffi, Antoine Néel, Raphaël Lecomte

Acute pulmonary embolism in COVID-19 related hypercoagulability

Cerruti Lorenzo, Boscaro Francesca, Poletto Francesco, Campello Elena, Spiezia Luca, Simioni Paolo

Thank you to reviewers

Richard C. Becker

Letter to the Editor

Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the γ-chain (p.Glu275Stop)

Tomas Simurda, Sonia Caccia, Rosanna Asselta, Jana Zolkova, Jan Stasko, Ingrid Skornova, Zuzana Snahnicanova, Dusan Loderer, Zora Lasabova, Peter Kubisz

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.